A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Clinical trial NCT00704080 · COMPLETED

Trial details

NCT number: NCT00704080
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mixed Gliomas Malignant Gliomas Glioblastoma Multiforme

Start date: 2008-08-01
Primary completion: 2012-02-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.